European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Czechia — market report, September 2026

Oncology drug tenders in Czechia in September 2026: 111 tenders published (+50% month on month, +46% year on year), estimated at €183,670,178 in total, and 127 contracts awarded (-22% month on month, -1% year on year), worth €38,596,431 (awarded value). Buyers with the most tenders: Fakultní nemocnice Ostrava (27), Fakultní nemocnice Olomouc (6) and Fakultní Thomayerova nemocnice (6); most contracts won: ROCHE s.r.o. (11), Merck Sharp & Dohme s.r.o. (7) and AbbVie s.r.o. (4). On average 4.0 bids per contract; 68% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
111
Contracts awarded
127
Contract value awarded
€38,596,431
Bids per contract
4.0
Tenders published per month
050100150Sep 25: 76Sep 25: 76Sep 25Oct 25: 118Oct 25: 118Oct 25Nov 25: 72Nov 25: 72Nov 25Dec 25: 84Dec 25: 84Dec 25Jan 26: 82Jan 26: 82Jan 26Feb 26: 103Feb 26: 103Feb 26Mar 26: 104Mar 26: 104Mar 26Apr 26: 91Apr 26: 91Apr 26May 26: 108May 26: 108May 26Jun 26: 74Jun 26: 74Jun 26Jul 26: 111Jul 26: 111Jul 26Aug 26: 74Aug 26: 74Aug 26Sep 26: 111Sep 26: 111111Sep 26
Contracts awarded per month
050100150200Sep 25: 128Sep 25: 128Sep 25Oct 25: 166Oct 25: 166Oct 25Nov 25: 143Nov 25: 143Nov 25Dec 25: 107Dec 25: 107Dec 25Jan 26: 89Jan 26: 89Jan 26Feb 26: 104Feb 26: 104Feb 26Mar 26: 111Mar 26: 111Mar 26Apr 26: 191Apr 26: 191Apr 26May 26: 146May 26: 146May 26Jun 26: 186Jun 26: 186Jun 26Jul 26: 154Jul 26: 154Jul 26Aug 26: 162Aug 26: 162Aug 26Sep 26: 127Sep 26: 127127Sep 26

The highlighted bar is September 2026. Hover a bar for its figure; the table below has every value.

FigureSeptember 2026August 2026ChangeSeptember 2025Change
Tenders published11174+50%76+46%
Estimated value€183,670,178€21,915,814+738%€10,769,804+1,605%
Buyers117+57%8+38%
Contracts awarded127162-22%128-1%
Contract value (awarded)€38,596,431€89,389,280-57%€16,271,572+137%
Winners1614+14%11+45%
Bids per contract4.02.2—4.0—
Single-bid contracts68%78%—63%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Hlavní město Praha 13
  • Olomoucký kraj 3
  • Plzeňský kraj 2
  • Jihomoravský kraj 2

Procedures

  • not stated 61
  • Open procedure 47
  • Negotiated procedure without prior publication 3

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Czechia in September 2026?
111 (by 11 buyers); for comparison, August 2026: 74, September 2025: 76.
Who won the most oncology drug tenders in Czechia in September 2026?
By number of contracts: ROCHE s.r.o. (11), Merck Sharp & Dohme s.r.o. (7), AbbVie s.r.o. (4), Avenier a.s. (4) and Takeda Pharmaceuticals Czech Republic s.r.o. (4); 16 companies won contracts in all.
Which buyers published the most oncology drug tenders in September 2026?
Fakultní nemocnice Ostrava (27), Fakultní nemocnice Olomouc (6), Fakultní Thomayerova nemocnice (6), Institut klinické a experimentální medicíny (4) and Oblastní nemocnice Mladá Boleslav, a.s., nemocnice Středočeského kraje (4).
How competitive were oncology drug tenders in Czechia in September 2026?
On average 4.0 bids per contract (66 contracts with a known number of bids); 68% of contracts had a single bid.
What were the contracts worth in September 2026?
€38,596,431 (awarded value, 127 contracts); median about €650,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.